Abbott rakes in earnings despite infant formula investigation but Nutrition suffers sales loss
date:Jul 22, 2022
ompany shut down the plant, citing heavy thunderstorms flooding the facility. The company resumed production on July 1, without making any official statement.

Earlier this month, we resumed partial production at that facility, starting with our specialty formula EleCare and metabolic formulas. We are in the final phases of testing to restart Similac production. As a reminder, once we begin production, it takes several weeks for the product to reach store shelves.

That said, we will do everyth
9/11 next page prev page home page last page
go back |  refresh |  WAP home |  Web page version  | login
05/20 01:15